Table 1.
Reduction in Viability (%) | ||||
---|---|---|---|---|
Sample Formulation | 30 min | 60 min | 120 min | |
PLA/Ag/PEG (rec-01) | S. aureus | 36.42 ± 2.02 | 57.20 ± 0.88 | 74.91 ± 3.78 |
E. coli | 79.17 ± 0.55 | 90.01 ± 0.95 | 94.86 ± 1.22 | |
PLA/Ag/PEG (rec-02) | S. aureus | 28.23 ± 3.08 | 47.45 ± 3.88 | 62.96 ± 5.78 |
E. coli | 49.17 ± 0.52 | 76.68 ± 0.95 | 88.97 ± 1.45 | |
PLA/Ag/PVP (rec-03) | S. aureus | 33.42 ± 3.02 | 52.20 ± 0.81 | 68.93 ± 3.32 |
E. coli | 60.17 ± 0.85 | 83.85 ± 0.95 | 92.97 ± 1.12 | |
PLA/Ag/PVP (rec-04) | S. aureus | 22.35 ± 2.68 | 40.21 ± 3.88 | 50.95 ± 5.78 |
E. coli | 46.17 ± 0.88 | 68.08 ± 0.99 | 73.28 ± 1.95 |